Novel compounds of the formula I
in which
R
1
, D, E, W, X and n are as defined in claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.
                            公式I的新化合物,其中R1、D、E、W、X和n如权利要求1所定义,是
凝血因子Xa的
抑制剂,可用于预防和/或治疗血栓栓塞性疾病和肿瘤的治疗。